Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 130

1.

Chemokine CXCL16 suppresses liver metastasis of colorectal cancer via augmentation of tumor-infiltrating natural killer T cells in a murine model.

Kee JY, Ito A, Hojo S, Hashimoto I, Igarashi Y, Tsukada K, Irimura T, Shibahara N, Nakayama T, Yoshie O, Sakurai H, Saiki I, Koizumi K.

Oncol Rep. 2013 Mar;29(3):975-82. doi: 10.3892/or.2012.2185.

PMID:
23242131
2.

Chemokine receptor CXCR6-dependent hepatic NK T Cell accumulation promotes inflammation and liver fibrosis.

Wehr A, Baeck C, Heymann F, Niemietz PM, Hammerich L, Martin C, Zimmermann HW, Pack O, Gassler N, Hittatiya K, Ludwig A, Luedde T, Trautwein C, Tacke F.

J Immunol. 2013 May 15;190(10):5226-36. doi: 10.4049/jimmunol.1202909.

3.

CXCL16 suppresses liver metastasis of colorectal cancer by promoting TNF-α-induced apoptosis by tumor-associated macrophages.

Kee JY, Ito A, Hojo S, Hashimoto I, Igarashi Y, Tsuneyama K, Tsukada K, Irimura T, Shibahara N, Takasaki I, Inujima A, Nakayama T, Yoshie O, Sakurai H, Saiki I, Koizumi K.

BMC Cancer. 2014 Dec 15;14:949. doi: 10.1186/1471-2407-14-949.

4.

High-level expression of chemokine CXCL16 by tumor cells correlates with a good prognosis and increased tumor-infiltrating lymphocytes in colorectal cancer.

Hojo S, Koizumi K, Tsuneyama K, Arita Y, Cui Z, Shinohara K, Minami T, Hashimoto I, Nakayama T, Sakurai H, Takano Y, Yoshie O, Tsukada K, Saiki I.

Cancer Res. 2007 May 15;67(10):4725-31.

5.

Cell surface-anchored SR-PSOX/CXC chemokine ligand 16 mediates firm adhesion of CXC chemokine receptor 6-expressing cells.

Shimaoka T, Nakayama T, Fukumoto N, Kume N, Takahashi S, Yamaguchi J, Minami M, Hayashida K, Kita T, Ohsumi J, Yoshie O, Yonehara S.

J Leukoc Biol. 2004 Feb;75(2):267-74.

PMID:
14634054
6.

Enhanced tumor metastasis in response to blockade of the chemokine receptor CXCR6 is overcome by NKT cell activation.

Cullen R, Germanov E, Shimaoka T, Johnston B.

J Immunol. 2009 Nov 1;183(9):5807-15. doi: 10.4049/jimmunol.0803520.

7.

The chemokine receptor CXCR6 and its ligand CXCL16 are expressed in carcinomas and inhibit proliferation.

Meijer J, Ogink J, Kreike B, Nuyten D, de Visser KE, Roos E.

Cancer Res. 2008 Jun 15;68(12):4701-8. doi: 10.1158/0008-5472.CAN-08-0482. Retraction in: Ogink J, Kreike B, Nuyten D, de Visser KE, Roos E. Cancer Res. 2011 Feb 1;71(3):1196.

8.

Upregulation of SR-PSOX/CXCL16 and recruitment of CD8+ T cells in cardiac valves during inflammatory valvular heart disease.

Yamauchi R, Tanaka M, Kume N, Minami M, Kawamoto T, Togi K, Shimaoka T, Takahashi S, Yamaguchi J, Nishina T, Kitaichi M, Komeda M, Manabe T, Yonehara S, Kita T.

Arterioscler Thromb Vasc Biol. 2004 Feb;24(2):282-7.

9.

Critical role for CXC chemokine ligand 16 (SR-PSOX) in Th1 response mediated by NKT cells.

Shimaoka T, Seino K, Kume N, Minami M, Nishime C, Suematsu M, Kita T, Taniguchi M, Matsushima K, Yonehara S.

J Immunol. 2007 Dec 15;179(12):8172-9.

11.

CXCL16/SR-PSOX is an interferon-gamma-regulated chemokine and scavenger receptor expressed in atherosclerotic lesions.

Wuttge DM, Zhou X, Sheikine Y, Wågsäter D, Stemme V, Hedin U, Stemme S, Hansson GK, Sirsjö A.

Arterioscler Thromb Vasc Biol. 2004 Apr;24(4):750-5.

12.

Distribution and kinetics of SR-PSOX/CXCL16 and CXCR6 expression on human dendritic cell subsets and CD4+ T cells.

Tabata S, Kadowaki N, Kitawaki T, Shimaoka T, Yonehara S, Yoshie O, Uchiyama T.

J Leukoc Biol. 2005 May;77(5):777-86.

PMID:
15703197
13.

Critical role for the chemokine receptor CXCR6 in homeostasis and activation of CD1d-restricted NKT cells.

Germanov E, Veinotte L, Cullen R, Chamberlain E, Butcher EC, Johnston B.

J Immunol. 2008 Jul 1;181(1):81-91.

14.

Loss of SMAD4 from colorectal cancer cells promotes CCL15 expression to recruit CCR1+ myeloid cells and facilitate liver metastasis.

Itatani Y, Kawada K, Fujishita T, Kakizaki F, Hirai H, Matsumoto T, Iwamoto M, Inamoto S, Hatano E, Hasegawa S, Maekawa T, Uemoto S, Sakai Y, Taketo MM.

Gastroenterology. 2013 Nov;145(5):1064-1075.e11. doi: 10.1053/j.gastro.2013.07.033.

PMID:
23891973
15.

Expression and regulation of the chemokine CXCL16 in Crohn's disease and models of intestinal inflammation.

Diegelmann J, Seiderer J, Niess JH, Haller D, Göke B, Reinecker HC, Brand S.

Inflamm Bowel Dis. 2010 Nov;16(11):1871-81. doi: 10.1002/ibd.21306.

16.

CD10 enhances metastasis of colorectal cancer by abrogating the anti-tumoural effect of methionine-enkephalin in the liver.

Kuniyasu H, Luo Y, Fujii K, Sasahira T, Moriwaka Y, Tatsumoto N, Sasaki T, Yamashita Y, Ohmori H.

Gut. 2010 Mar;59(3):348-56. doi: 10.1136/gut.2009.178376.

PMID:
19828468
17.

SR-PSOX/CXCL16 plays a critical role in the progression of colonic inflammation.

Uza N, Nakase H, Yamamoto S, Yoshino T, Takeda Y, Ueno S, Inoue S, Mikami S, Matsuura M, Shimaoka T, Kume N, Minami M, Yonehara S, Ikeuchi H, Chiba T.

Gut. 2011 Nov;60(11):1494-505. doi: 10.1136/gut.2010.221879.

PMID:
21471570
18.

Soluble CXCL16 in preoperative serum is a novel prognostic marker and predicts recurrence of liver metastases in colorectal cancer patients.

Matsushita K, Toiyama Y, Tanaka K, Saigusa S, Hiro J, Uchida K, Inoue Y, Kusunoki M.

Ann Surg Oncol. 2012 Jul;19 Suppl 3:S518-27. doi: 10.1245/s10434-011-1993-8.

PMID:
21845497
19.

An alternatively spliced CXCL16 isoform expressed by dendritic cells is a secreted chemoattractant for CXCR6+ cells.

van der Voort R, Verweij V, de Witte TM, Lasonder E, Adema GJ, Dolstra H.

J Leukoc Biol. 2010 Jun;87(6):1029-39. doi: 10.1189/jlb.0709482.

20.

Repair-related activation of hedgehog signaling promotes cholangiocyte chemokine production.

Omenetti A, Syn WK, Jung Y, Francis H, Porrello A, Witek RP, Choi SS, Yang L, Mayo MJ, Gershwin ME, Alpini G, Diehl AM.

Hepatology. 2009 Aug;50(2):518-27. doi: 10.1002/hep.23019.

Items per page

Supplemental Content

Support Center